In 2023, branded obesity drug sales reached $6 billion, and this figure is expected to grow exponentially as demand continues to rise and these medications are used to treat a broader range of diseases
Understanding the broader peptide landscape Semaglutide is one compound in a rapidly growing field
If youve repeatedly been denied prior authorization for Ozempic, talk to your healthcare provider about your options
What to Expect During Your Consultation When you consult with a compounding pharmacist, expect a thorough discussion of your medical history, current medications, and specific health goals
Almost every telehealth company that offers STI care requires that your STI situation is a flare-up of something youve seen a provider in-person for a diagnosis and treatment before
LEADER (liraglutide) : In the LEADER trial, liraglutide lowered major cardiovascular events by 31% and all-cause mortality by 26% in type 2 diabetes patients with chronic kidney disease, compared with placebo